Screener
Jade Biosciences JBIO Total Assets
Total Assets at other companies
Other financials
Where this comes from
Reported directly by Jade Biosciences in its filing.
Tagged under the XBRL concept us-gaap:Assets.
The source filing: Jade Biosciences’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 4:27 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-212088
| Line item | March 31,2026 | December 31,2025 |
|---|---|---|
| Property and equipment, net | 157 | 170 |
| Operating lease right-of-use asset | 690 | 726 |
| Other assets | 69 | 69 |
| Total assets | $319,433 | $349,781 |
| Liabilities, Convertible Preferred Stock and Stockholders' Equity (Deficit) | ||
| Current liabilities: | ||
| Accounts payable | 3,979 | 2,151 |
| Accrued expenses and other current liabilities | 14,852 | 9,419 |
Item 1. Financial Statements.
FAQ
- What is Jade Biosciences's total assets?
- Jade Biosciences (JBIO) reported total assets of $319.43M in Q1 2026.
- How has Jade Biosciences's total assets changed year-over-year?
- Jade Biosciences's total assets increased by 312.0% year-over-year, from $77.53M to $319.43M.
- What is the long-term trend for Jade Biosciences's total assets?
- Over 5 years (2020 to 2025), Jade Biosciences's total assets has grown at a 136.6% compound annual growth rate (CAGR), from $4.72M to $349.78M.
- What does total assets mean?
- The sum of everything the company owns — current assets, property, investments, goodwill, intangibles, and all other assets.
Ask your AI about Jade Biosciences's total assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude